MONTREAL (AP) _ Aeterna Zentaris Inc. (AEZS) on Wednesday reported a loss of $9.6 million in its third quarter.
On a per-share basis, the Montreal-based company said it had a loss of 61 cents. Losses, adjusted for non-recurring costs, came to 44 cents per share.
The drug developer posted revenue of $241,000 in the period.
The company's shares closed at $1.90. A year ago, they were trading at $3.25.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AEZS at https://www.zacks.com/ap/AEZS